FOXO4-DRI (10mg)

1. Overview of FOXO4-DRI 10mg

FOXO4-DRI is a pioneering senolytic peptide designed as a retro-inverso D-amino acid antagonist that selectively disrupts the interaction between FOXO4 and the p53 tumor suppressor protein. By preventing FOXO4 from sequestering p53 in the nucleus of senescent cells, the peptide triggers targeted apoptosis in these non-dividing “zombie cells” while leaving healthy, functional cells unaffected.

2. Key Benefits

• Main Effect: FOXO4-DRI serves as a potent senolytic agent that promotes cellular renewal by selectively eliminating senescent cells that contribute to tissue dysfunction and chronic inflammation.
• Health Benefits: Research indicates significant potential in improving vascular function, reducing age-related inflammation markers, and supporting the restoration of tissue homeostasis across various organ systems.
• Optimization Efficiency: This peptide offers high capability for optimizing physical conditioning and biological resilience by clearing the cellular “debris” that impedes natural repair mechanisms and energetic efficiency.

3. Usage & Storage Guidelines

Researchers must strictly follow established laboratory protocols during application. Note that storage is mandatory in the refrigerator at 2-8?C after reconstitution, and keep away from direct sunlight to avoid degradation of the peptide.

Note: This product is for laboratory research purposes only.